Wednesday, January 16, 2013 10:02:11 AM
Now part of it is the huge unexercised warrant overhang which is scaring away long term buyers because they equate it future dilution and lower pps. the other part is the additional $3.5 to $5 million more of capital needed to finance the business plan. this too is equated with future dilution.
But what is quite worrisome is why people are not seeing through this to the supposed game changing technology, the number of potential applications as listed in te 10K - did anybody notice they did not list Erictile dysfunction - and the hiring of Atlas and the ONGOING search for partners, and bidding the stock up substantially...
There are plenty of Bio pharma stocks that sport $100, $500 evena $1 billion dollar market caps and have zero revenues....
There is something in all of this that is not resulting in the big buying by the big money....there is something in the research etc. that is not convincing....
i wish I knew what it was.....and no it isn't that people have not heard of drop...please....
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM